Xeris Biopharma Holdings, Inc.
XERS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001867096
In the last 90 days, Xeris Biopharma Holdings, Inc. insiders filed 0 open-market purchases and 9 sales; 242 institutions reported holding it in 13F filings for Q2 2026, worth $857.1M in total; no superinvestor holds it.
Superinvestors holding XERS, Q2 2026
No superinvestor reported holding XERS in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of XERS each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2025
0 superinvestors holding at quarter end
- Sold out
- Fairfax Financial
Q4 2024
1 superinvestor holding at quarter end
- Reduced
- Fairfax Financial (−18.3%)
Q2 2024
1 superinvestor holding at quarter end
- Added
- Fairfax Financial (+12.9%)
Q4 2021
1 superinvestor holding at quarter end